Literature DB >> 20533500

A structure-activity relationship study of the antimalarial and antileishmanial activities of nonpeptide macrocyclic histone deacetylase inhibitors.

William Guerrant1, Sandra C Mwakwari, Po C Chen, Shabana I Khan, Babu L Tekwani, Adegboyega K Oyelere.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20533500      PMCID: PMC3138184          DOI: 10.1002/cmdc.201000087

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


× No keyword cloud information.
  31 in total

Review 1.  Epigenetic therapy of cancer: past, present and future.

Authors:  Christine B Yoo; Peter A Jones
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

2.  Broad spectrum antiprotozoal agents that inhibit histone deacetylase: structure-activity relationships of apicidin. Part 1.

Authors:  S L Colletti; R W Myers; S J Darkin-Rattray; A M Gurnett; P M Dulski; S Galuska; J J Allocco; M B Ayer; C Li; J Lim; T M Crumley; C Cannova; D M Schmatz; M J Wyvratt; M H Fisher; P T Meinke
Journal:  Bioorg Med Chem Lett       Date:  2001-01-22       Impact factor: 2.823

3.  A simple colorimetric method to screen drug cytotoxicity against Leishmania using the dye Alamar Blue.

Authors:  J Mikus; D Steverding
Journal:  Parasitol Int       Date:  2000-01       Impact factor: 2.230

Review 4.  Discovery and development of SAHA as an anticancer agent.

Authors:  P A Marks
Journal:  Oncogene       Date:  2007-02-26       Impact factor: 9.867

5.  Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase.

Authors:  S J Darkin-Rattray; A M Gurnett; R W Myers; P M Dulski; T M Crumley; J J Allocco; C Cannova; P T Meinke; S L Colletti; M A Bednarek; S B Singh; M A Goetz; A W Dombrowski; J D Polishook; D M Schmatz
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-12       Impact factor: 11.205

6.  Proof of interaction between Leishmania SIR2RP1 deacetylase and chaperone HSP83.

Authors:  Monte-Alegre Adriano; Baptiste Vergnes; Joel Poncet; Françoise Mathieu-Daude; Anabela Cordeiro da Silva; Ali Ouaissi; Denis Sereno
Journal:  Parasitol Res       Date:  2006-11-10       Impact factor: 2.289

7.  The global distribution of clinical episodes of Plasmodium falciparum malaria.

Authors:  Robert W Snow; Carlos A Guerra; Abdisalan M Noor; Hla Y Myint; Simon I Hay
Journal:  Nature       Date:  2005-03-10       Impact factor: 49.962

8.  Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity.

Authors:  M T Makler; J M Ries; J A Williams; J E Bancroft; R C Piper; B L Gibbins; D J Hinrichs
Journal:  Am J Trop Med Hyg       Date:  1993-06       Impact factor: 2.345

9.  Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group.

Authors:  Vishal Patil; William Guerrant; Po C Chen; Berkley Gryder; Derek B Benicewicz; Shabana I Khan; Babu L Tekwani; Adegboyega K Oyelere
Journal:  Bioorg Med Chem       Date:  2009-10-27       Impact factor: 3.641

10.  Inhibition of Plasmodium falciparum proliferation in vitro by double-stranded RNA directed against malaria histone deacetylase.

Authors:  N Sriwilaijaroen; S Boonma; P Attasart; J Pothikasikorn; S Panyim; W Noonpakdee
Journal:  Biochem Biophys Res Commun       Date:  2009-01-31       Impact factor: 3.575

View more
  3 in total

1.  Non-peptide macrocyclic histone deacetylase inhibitors derived from tricyclic ketolide skeleton.

Authors:  Sandra C Mwakwari; William Guerrant; Vishal Patil; Shabana I Khan; Babu L Tekwani; Zachary A Gurard-Levin; Milan Mrksich; Adegboyega K Oyelere
Journal:  J Med Chem       Date:  2010-08-26       Impact factor: 7.446

2.  The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.

Authors:  Quaovi Sodji; Vishal Patil; Surendra Jain; James R Kornacki; Milan Mrksich; Babu L Tekwani; Adegboyega K Oyelere
Journal:  Bioorg Med Chem Lett       Date:  2014-09-04       Impact factor: 2.823

3.  Inhibitors of human histone deacetylase with potent activity against the African trypanosome Trypanosoma brucei.

Authors:  John M Kelly; Martin C Taylor; David Horn; Einars Loza; Ivars Kalvinsh; Fredrik Björkling
Journal:  Bioorg Med Chem Lett       Date:  2012-01-28       Impact factor: 2.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.